MDM2 and CDK4 amplifications are rare events in salivary duct carcinomas.
Salivary duct carcinoma (SDC) is an aggressive adenocarcinoma of the salivary glands associated with poor clinical outcome. SDCs are known to carry TP53 mutations in about 50%, however, only little is known about alternative pathogenic mechanisms within the p53 regulatory network. Particularly, data on alterations of the oncogenes MDM2 and CDK4 located in the chromosomal region 12q13-15 are limited in SDC, while genomic rearrangements of the adjacent HMGA2 gene locus are well documented in subsets of SDCs. We here analyzed the mutational status of the TP53 gene, genomic amplification of MDM2, CDK4 and HMGA2 rearrangement/amplification as well as protein expression of TP53 (p53), MDM2 and CDK4 in 51 de novo and ex pleomorphic adenoma SDCs.25 of 51 cases were found to carry TP53 mutations, associated with extreme positive immunohistochemical p53 staining levels in 13 cases. Three out of 51 tumors had an MDM2 amplification, one of them coinciding with a CDK4 amplification and two with a HMGA2 rearrangement/amplification. Two of the MDM2 amplifications occurred in the setting of a TP53 mutation. Two out of 51 cases showed a CDK4 amplification, one synchronously being MDM2 amplified and the other one displaying concurrent low copy number increases of both, MDM2 and HMGA2.In summary, we here show that subgroups of SDCs display genomic amplifications of MDM2 and/or CDK4, partly in association with TP53 mutations and rearrangement/amplification of HMGA2. Further research is necessary to clarify the role of chromosomal region 12q13-15 alterations in SDC tumorigenesis and their potential prognostic and therapeutic relevance.
Department of Pathology, University Hospital Muenster, Muenster, Germany.
Inga
I
Grünewald
Department of Pathology, University Hospital Muenster, Muenster, Germany.
Marcel
M
Trautmann
Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Muenster, Muenster, Germany.
Alina
A
Busch
Department of Pathology, University Hospital Muenster, Muenster, Germany.
Larissa
L
Bauer
Department of Pathology, University Hospital Muenster, Muenster, Germany.
Sebastian
S
Huss
Institute of Pathology, University Hospital Cologne, Cologne, Germany.
Petra
P
Schweinshaupt
Institute of Pathology, University Hospital Cologne, Cologne, Germany.|Current address: Institute of Pathology, Charité University Hospital Berlin, Berlin, Germany .
Claudia
C
Vollbrecht
Institute of Pathology, University Hospital Cologne, Cologne, Germany.
Margarete
M
Odenthal
Institute of Pathology, University Hospital Cologne, Cologne, Germany.
Alexander
A
Quaas
Institute of Pathology, University Hospital Cologne, Cologne, Germany.
Reinhard
R
Büttner
Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Cologne, Cologne, Germany.
Moritz F
MF
Meyer
Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Cologne, Cologne, Germany.
Dirk
D
Beutner
Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Cologne, Cologne, Germany.
Karl-Bernd
KB
Hüttenbrink
Department of Pathology, University Hospital Muenster, Muenster, Germany.
Eva
E
Wardelmann
Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Muenster, Muenster, Germany.
Markus
M
Stenner
Department of Pathology, University Hospital Muenster, Muenster, Germany.
Wolfgang
W
Hartmann
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor; D051358:Cyclin-Dependent Kinase 4 / Q000235:genetics*; D005260:Female; D005784:Gene Amplification; D016158:Genes, p53; D006801:Humans; D007150:Immunohistochemistry; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D009154:Mutation; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D011379:Prognosis; D051736:Proto-Oncogene Proteins c-mdm2 / Q000235:genetics*; D012468:Salivary Gland Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000401:mortality / Q000628:therapy
D014408:Biomarkers, Tumor; D051736:Proto-Oncogene Proteins c-mdm2; D051358:Cyclin-Dependent Kinase 4
CDK4; HMGA2; MDM2; p53; salivary gland carcinoma
Cell. 1995 Jul 14;82(1):57-65
7606786
Mod Pathol. 2012 Nov;25(11):1473-80
22684217
Cancer Res. 2010 Oct 1;70(19):7684-9
20841468
Histopathology. 2013 Aug;63(2):250-62
23738717
Clin Cancer Res. 2014 Jul 1;20(13):3379-83
24795392
Genes Dev. 1997 Mar 15;11(6):714-25
9087426
J Clin Oncol. 2007 Jan 1;25(1):118-45
17159189
Cell Cycle. 2013 Sep 15;12(18):3063-9
23974099
Int J Cancer. 2008 May 15;122(10 ):2233-41
18214854
Genes Chromosomes Cancer. 2009 Jan;48(1):69-82
18828159
Clin Cancer Res. 2009 Sep 15;15(18):5696-703
19737942
Am J Surg Pathol. 2015 Jun;39(6):744-52
25723113
Oncotarget. 2015 Jul 20;6(20):18224-37
26053092
Science. 2004 Feb 6;303(5659):844-8
14704432
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15608-12
9861017
J Clin Pathol. 2003 Dec;56(12):914-8
14645349
Oncogene. 1997 Jun 19;14(24):2935-41
9205100
Nat Genet. 1995 Aug;10(4):436-44
7670494
Lancet Oncol. 2012 Nov;13(11):1133-40
23084521
Head Neck Pathol. 2012 Sep;6(3):328-35
22485045
Histopathology. 2014 Sep;65(3):340-52
24612173
Oncogene. 1999 Feb 18;18(7):1419-34
10050879
Mol Cell Biol. 2006 Dec;26(23 ):8840-56
16982679
Diagn Mol Pathol. 2006 Jun;15(2):83-9
16778588
Nat Rev Cancer. 2013 Feb;13(2):83-96
23303139